This article is more than 5 years old. Information may no longer be current.

Pentax Medical shares new GI, biliary technology presented at DDW

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Healio Gastroenterology and Liver Disease spoke with David G. Woods, president and CEO of Pentax Medical, about the company’s triple-aim initiative to enhance clinical outcomes, economic outcomes and patient-provider satisfaction.

“At Pentax, we’re very focused on delivering the triple-aim concept by also having the talent in the organization, whether it be for infection control, whether it be service or product utilization, whether it be clinical acumen and being able to support our customers,” Woods told Healio Gastroenterology and Liver Disease.

Additionally, Woods reviews three new products presented at DDW including a camera-containing capsule for short bowel syndrome, a new imaging platform for colonoscopy, and new endoscopic technology for pancreatic and biliary complications.

Disclosure: Woods is an employee of Pentax Medical.